Gennex Laboratories share news and announcements

BSE: 531739Pharmaceuticals & BiotechnologySmall Cap

₹8.70₹0.15 (1.69%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹8.85.

52-week range of traded prices to 23 Oct 2026

₹7.05Low, 30 Mar 2026₹17.25High, 28 Oct 2025

Market cap: ₹211 Cr2,248th largest listed
P/E: 11.5
P/B: 0.9
Dividend yield: Nonein the last 12 months
ROE: 9.0%
ROCE: 7.0%
Debt to equity: 0.15
Volume, BSE: 2,30,459

Gennex Laboratories share news and announcements

553 announcements, routine notices left out, newest first. Page 2 of 12.

Jul 2025
- 28 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve 1. the Unaudited Financial .... (opens in a new tab)
- 8 Jul · Board meeting
  Meeting on 8 Jul 2025: preferential issue of shares
- 8 Jul · Board meeting
  Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 .... (opens in a new tab)
- 7 Jul · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Premier Fiscal Services Pvt Ltd (opens in a new tab)
- 4 Jul · Board meeting
  Meeting on 4 Jul 2025: preferential issue of shares
- 4 Jul · Board meeting
  Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 .... (opens in a new tab)
Jun 2025
- 4 Jun · Board meeting
  Meeting on 4 Jun 2025: preferential issue of shares
- 4 Jun · Board meeting
  Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015 ('Listing Regulations') read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, .... (opens in a new tab)
May 2025
- 30 May · Management
  ("Listing Regulations" we would like to inform you that based on the recommendation of the Nomination .... (opens in a new tab)
- 30 May · Management
  With reference to the above captioned subject matter, this is to inform that Dr.S Ch Dharma Rao, Non-Executive Non-Independent Director has tendered his resignation from the Board as Director .... (opens in a new tab)
- 30 May · Results
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Audited Standalone & Consolidated Financial results for the Quarter & Year ended .... (opens in a new tab)
- 30 May · Board meeting
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Audited Standalone & Consolidated Financial results for the Quarter & Year .... (opens in a new tab)
- 22 May · Approval Of Additional Products From Drugs Control Administration, Government Of Andhra Pradesh For Our Subsidiary Company, Deccan Remedies Limited
  We are pleased to inform you that our Subsidiary Company, M/s Deccan Remedies Limited, has received Approval from the Drugs Control Administration, Government of Andhra Pradesh granting .... (opens in a new tab)
- 20 May · Board meeting
  Meeting on 30 May 2025: audited results
- 20 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1. Consider and adopt the .... (opens in a new tab)
Mar 2025
Feb 2025
Nov 2024
- 14 Nov · Results
  In just concluded Meeting of Board of Directors, the Board approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter .... (opens in a new tab)
- 14 Nov · Results
  In just Concluded Meeting of Board of Directors the Board approved and considered the following items: 1. Unaudited Financial Statements for the Quarter and Half year ended September 30, .... (opens in a new tab)
- 14 Nov · Intimation Of Reconstitution Of Audit Committee, Stakeholders Relationship Committee And Nomination And Remuneration Committee Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015.
  We wish to inform you that the Board of Directors of the Company in their meeting held on November 14, 2024, reconstituted their .... (opens in a new tab)
- 14 Nov · Management
  We would like to inform you that the Board of Directors at its meeting held today .... (opens in a new tab)
- 14 Nov · Business
  We hereby confirm that there is no deviation or variation in the use of proceeds during the quarter ended September 30, 2024, .... (opens in a new tab)
- 5 Nov · Board meeting
  Meeting on 14 Nov 2024: quarterly results
- 5 Nov · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve 1. Consider and adopt .... (opens in a new tab)
Oct 2024
- 28 Oct · Grant Of Test License By Drugs Control Administration, Government Of Andhra Pradesh To Our Subsidiary Company, Deccan Remedies Limited
  We are pleased to inform you that our subsidiary Company, M/s Deccan Remedies Limited has been granted Test License by the Drugs Control Administration, Government of Andhra Pradesh for .... (opens in a new tab)
- 28 Oct · Approval Of Additional Products From Drug Control Administration, Government Of Andhra Pradesh For Our Subsidiary Company, Deccan Remedies Limited
  We are pleased to inform that our Subsidiary Company, M/s Deccan Remedies Limited has received Approval from Drugs Control Administration, Government of Andhra Pradesh granting manufacture .... (opens in a new tab)
- 4 Oct · Management
  This has reference to email dated February 20, 2024 regarding BSE observation that required details under SEBI Circular No. 2023/123 dated 13.07.2023 is not mentioned in our Announcement .... (opens in a new tab)
- 1 Oct · Meeting
  In compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, as amended from time to time (Listing Regulations), please find enclosed herewith voting results of the 39th AGM of the .... (opens in a new tab)
- 1 Oct · Management
  We would like to inform you that the Company has received approval of its members by Special .... (opens in a new tab)
Sep 2024
Aug 2024
- 28 Aug · Board meeting
  Meeting on 6 Sep 2024: annual general meeting
- 28 Aug · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2024 ,inter alia, to consider and approve 1. To decide regarding .... (opens in a new tab)
- 14 Aug · Business
  We hereby confirm that there is no deviation or variation in the use of the proceeds, from the objects stated in the letter of .... (opens in a new tab)
- 14 Aug · Management
  Pursuant to Regulation 30 read with Para A Part A of Schedule III of SEBI (LODR), 2015, this is to inform you that Mr. Laxmipat Baid has tendered his resignation from the post of Chief .... (opens in a new tab)
- 14 Aug · Board meeting
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter .... (opens in a new tab)
- 14 Aug · Results
  Board approved and considered the followings in the meeting held on August 14, 2024: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30, 2024 2. .... (opens in a new tab)
- 5 Aug · Board meeting
  Meeting on 14 Aug 2024: quarterly results

Gennex Laboratories share news and announcements

Jul 2025

Jun 2025

May 2025

Mar 2025

Feb 2025

Nov 2024

Oct 2024

Sep 2024

Aug 2024